Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

t fully controlled despite treatment with one or two other antiepileptic drugs. The third study is a randomized, double-blind, placebo-controlled trial with flexible dosing designed to evaluate the safety and tolerability of brivaracetam in patients with uncontrolled partial onset or primary generalized seizures. First results of these studies are expected in mid 2009.

About Brivaracetam: Brivaracetam has distinct pharmacological differences as well as having some structural similarity to the AED Keppra(R) (levetiracetam). In preclinical studies brivaracetam was shown to have a 10- fold higher affinity for synaptic vesicle protein 2A (SV2A) than Keppra(R). Brivaracetam also has inhibitory activity at neuronal voltage-dependent sodium channels whose abnormal function is understood to contribute to electrical discharges associated with seizures. These differences may explain brivaracetam's antiepileptic activity, clinical efficacy and tolerability.

About Epilepsy: Epilepsy is a chronic neurological disorder affecting more than 2.5 million Americans regardless of race, age or sex. Between 70-80% of individuals are successfully treated with one of the more than 20 antiepileptic drugs now available. However, 20-30% of patients have either intractable or uncontrolled seizures or have significant adverse side effects secondary to medication, highlighting the ongoing need for the development of new antiepileptic drugs.

About Keppra(R) in the U.S.: Keppra(R) tablets and oral solution are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy, myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Keppra(R) injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in JME
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Follow us on ... growth worldwide, supported by the numerous intraoperative, and ... and single incision surgery will continue to spur ... invasive surgery, driving its adoption among patients and ... site, lower blood loss, shorter hospital stays, faster ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Bird B ... industrial and residential applications now offers its popular plastic ... The humane, highly efficient bird deterrent is ... match the color and décor of the building or ... colors—brick red, white, crystal clear, light grey, brown, black ...
(Date:3/4/2015)... Mexia, Texas & Ennis, Texas (PRWEB) March 04, ... Ennis Regional Medical Center today announced that Alan ... of both hospitals, effective immediately. Daugherty has served ... Regional since October 2014. , “Alan has provided ... and has demonstrated exceptional abilities leading hospital strategy ...
(Date:3/3/2015)... Anik Singal's Profit Academy ... ambitious online marketers has become the talk of ... media attention surrounding the course's general release has ... Hendricks, prompting her to review the program's content ... of the biggest keys to success with Internet ...
(Date:3/3/2015)... Loma Linda University Health announced today, ... being, it will be offering new, healthier choices in ... Over the past year, a cross-section of Loma Linda ... criteria, listening to vendors, sampling their products, and ultimately ... , Most recently, a food fair was held during ...
Breaking Medicine News(10 mins):Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Demand for Less Invasive Procedures Drives Growth in the Endoscopy Systems Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 2Health News:Alan Daugherty Named CEO of Parkview Regional Hospital and Ennis Regional Medical Center 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2
... from the University of Washington, Seattle, and colleagues, have ... Moderately elevated levels of insulin increase the levels ... in cerebrospinal fluid and these markers may contribute to ... healthy older adults ranging in age from 55 to ...
... Hyderabad has unraveled the mystery behind gene silencing, paving ... in human beings//. ,Two scientists - Manika Pal ... novel finding to fight a disease, which has remained ... silencing segments of the genes (heterochromatin), which are responsible ...
... is a complex decision and early detection of cancer will ... problems for others leading to unnecessary testing and treatment. Celebrities ... can be used for early detection of cancer// , ... in the Journal of the National Cancer Institute reported that ...
... University School of Medicine had said in a research finding ... that the disease called Rocky Mountain spotted fever may spread ... ,The research highlights the importance of the recent outbreak ... be traced back to ticks carried into to the state ...
... has been designed to help researchers track a tracer chemical, monamine ... enzyme has been found to play a crucial role in blood ... B. ,The study showed that levels of MAO B ... - were reduced by 40 to 50 percent compared to non-smokers. ...
... elderly people who exercise regularly and have a certain gene ... movements than the people who lack the gene expression. ... School of Medicine was published // in the latest issue ... climbing steps) is common and is strongly related to major ...
Cached Medicine News:Health News:Influence of Celebrities on Breast Cancer Awareness 2Health News:Influence of Celebrities on Breast Cancer Awareness 3Health News:Influence of Celebrities on Breast Cancer Awareness 4Health News:Influence of Celebrities on Breast Cancer Awareness 5Health News:Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts 2Health News:Gene Variation Associated With Better Mobility For Older Individuals 2
(Date:3/3/2015)...  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) ... engaged in the design, development and production of ... medical device companies has announced the acquisition of ... medical cable manufacturer based in North Carolina.  The ... the name MTI Medical Cables.  ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... Registration is officially open for MEDTEC China South ... the Shenzhen Convention & Exhibition Center. The Shenzhen ... join the MEDTEC China family of events. MEDTEC China South, ... better serve the South China market ... important region for China,s medical device ...
Breaking Medicine Technology:American Biosurgical Acquires MTI Corporation 2Web Industries Receives 3M Preferred Converter Status 2Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3
... , VIENNA, Va., Dec. 1 CEL-SCI Corporation (NYSE Amex: ... of vaccines and therapeutics for the prevention and treatment of ... of an international Contract Research Organization (CRO) to run CEL-SCI,s ... neck cancer with the Company,s lead product candidate, Multikine®. ...
... , MT. LAUREL, N.J., Dec. 1 MedQuist ... clinical documentation services, today announced that the radiology search tool ... Radiology(TM), MedQuist,s real-time speech recognition system. The solution is being ... November 29 through December 2. , Radiologists ...
Cached Medicine Technology:CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2
... Only 1-2% of circulating testosterone exists as ... 60%, is bound to SHBG with high ... bound to albumin. Both the albumin-bound and ... SHBG effectively inhibits testosterone action. Measurement of ...
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... Human Insulin-like growth factor binding protein-3 (IGFBP-3) is ... in postnatal serum, as a component of the ... IGFBP-3, a molecule of IGF-I or IGF-II and ... the actions of the IGFs. The molar concentration ...
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
Medicine Products: